Skip to main content
Skip to main content
AMEH logo

Apollo Medical Holdings, Inc. (AMEH)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Apollo Medical Holdings, Inc. (AMEH) trades at $40.82 with AI Score 55/100 (Hold). Apollo Medical Holdings, Inc. operates as a physician-centric, technology-powered healthcare company, focusing on value-based care. Market cap: 2B, Sector: Healthcare.

Last analyzed: Feb 8, 2026
Apollo Medical Holdings, Inc. operates as a physician-centric, technology-powered healthcare company, focusing on value-based care. The company leverages its integrated platform to coordinate care for patients across various settings, primarily in California.
55/100 AI Score MCap 2B Vol 314K

Apollo Medical Holdings, Inc. (AMEH) Healthcare & Pipeline Overview

CEOBrandon Sim
Employees1362
HeadquartersAlhambra, CA, US
IPO Year2009

Apollo Medical Holdings leverages its technology-driven platform and integrated care model to empower physicians, improve patient outcomes, and manage population health, primarily serving patients covered by private and public insurance in California, offering a compelling value proposition in the evolving healthcare landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Apollo Medical Holdings presents a notable research candidate due to its integrated, value-based care model and technology-driven platform. The company's focus on care coordination and population health management positions it to benefit from the increasing demand for efficient and effective healthcare delivery. While the company's current P/E ratio is high at 108.83, its potential for growth in the value-based care market, particularly in California, is significant. Key value drivers include expanding its network of physicians, increasing its patient base, and improving care outcomes. The company's beta of 1.04 suggests a market-correlated risk profile. The absence of a dividend may deter some investors, but the potential for capital appreciation through growth makes AMEH an attractive investment for those seeking exposure to the evolving healthcare landscape.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $1.83 billion, reflecting investor confidence in the company's growth potential.
  • High P/E ratio of 108.83, indicating expectations of future earnings growth.
  • Gross margin of 10.1%, reflecting the company's ability to manage costs in its healthcare delivery model.
  • Profit margin of 0.3%, indicating room for improvement in operational efficiency.
  • Beta of 1.04, suggesting the stock's volatility is similar to the overall market.

Competitors & Peers

Strengths

  • Integrated, value-based care model.
  • Proprietary technology platform.
  • Established network of physicians.
  • Focus on care coordination.

Weaknesses

  • High P/E ratio.
  • Low profit margin.
  • Geographic concentration in California.
  • Dependence on government and private insurance reimbursement.

Catalysts

  • Expansion of the physician network and patient base.
  • Development and enhancement of the technology platform.
  • Potential acquisitions of complementary healthcare providers.
  • Increasing adoption of value-based care models by payers.

Risks

  • Changes in healthcare regulations and reimbursement policies.
  • Increased competition from other healthcare providers.
  • Economic downturn affecting patient access to care.
  • Cybersecurity risks and data breaches.
  • Dependence on government and private insurance reimbursement.

Growth Opportunities

  • Expansion within California: Apollo Medical Holdings has a significant opportunity to expand its presence within California, leveraging its existing infrastructure and network to reach new patient populations and geographic areas. The California healthcare market is substantial, with a large number of insured and uninsured individuals seeking access to quality care. By strategically targeting underserved areas and partnering with local healthcare providers, Apollo Medical Holdings can increase its market share and drive revenue growth. This expansion can be achieved within the next 2-3 years.
  • Penetration of New Markets: While currently focused on California, Apollo Medical Holdings can explore opportunities to expand its operations into new states with favorable regulatory environments and growing demand for value-based care. States with large Medicare and Medicaid populations, as well as those actively promoting population health management initiatives, represent attractive targets for expansion. This strategic move could diversify the company's revenue streams and reduce its reliance on the California market. This expansion is a 3-5 year goal.
  • Enhancement of Technology Platform: Investing in further development and enhancement of its proprietary technology platform will enable Apollo Medical Holdings to improve care coordination, streamline operations, and enhance the patient experience. By incorporating advanced analytics, artificial intelligence, and machine learning capabilities, the platform can provide real-time insights, personalized care recommendations, and proactive interventions. This ongoing investment in technology will drive efficiency and improve patient outcomes.
  • Strategic Partnerships and Acquisitions: Apollo Medical Holdings can pursue strategic partnerships and acquisitions to expand its service offerings, enhance its geographic reach, and gain access to new technologies and expertise. Collaborating with other healthcare providers, technology companies, and managed care organizations can create synergies and accelerate growth. Identifying and acquiring companies with complementary capabilities can strengthen Apollo Medical Holdings' competitive position and drive long-term value creation. These partnerships and acquisitions are an ongoing opportunity.
  • Increased Focus on Medicare and Medicaid Populations: With a significant portion of its patient base covered by Medicare and Medicaid, Apollo Medical Holdings can further specialize its services and programs to meet the unique needs of these populations. By developing tailored care plans, addressing social determinants of health, and improving access to preventive services, the company can enhance patient outcomes, reduce healthcare costs, and improve its financial performance. This focus requires continuous refinement and innovation.

Opportunities

  • Expansion within California and into new markets.
  • Increased focus on Medicare and Medicaid populations.
  • Strategic partnerships and acquisitions.
  • Further development of technology platform.

Threats

  • Changes in healthcare regulations and reimbursement policies.
  • Increased competition from other healthcare providers.
  • Economic downturn affecting patient access to care.
  • Cybersecurity risks and data breaches.

Competitive Advantages

  • Proprietary technology platform for population health management.
  • Integrated, value-based care model.
  • Established network of physicians and healthcare providers.
  • Focus on care coordination and patient engagement.

About AMEH

Founded in 1994 and headquartered in Alhambra, California, Apollo Medical Holdings, Inc. (AMEH) has evolved into a physician-centric, technology-powered healthcare company. The company operates an integrated, value-based healthcare model, leveraging its proprietary population health management and healthcare delivery platform. This platform empowers providers within its network to deliver enhanced care to their patients. Apollo Medical Holdings offers comprehensive care coordination services, connecting patients, families, primary care physicians, specialists, acute care hospitals, alternative inpatient care sites, physician groups, and health plans. The company's physician network includes primary care physicians, specialist physicians, and hospitalists, ensuring a broad spectrum of medical expertise. AMEH primarily serves patients covered by private or public insurance, including Medicare, Medicaid, and health maintenance organization plans, as well as non-insured patients in California. The company's focus on technology and integrated care positions it to capitalize on the shift towards value-based healthcare models.

What They Do

  • Provides medical care services to patients in California.
  • Operates an integrated, value-based healthcare model.
  • Leverages a proprietary population health management and healthcare delivery platform.
  • Offers care coordination services to patients, families, and healthcare providers.
  • Manages a network of primary care physicians, specialists, and hospitalists.
  • Serves patients covered by private or public insurance, including Medicare and Medicaid.
  • Provides services to non-insured patients.

Business Model

  • Generates revenue through providing medical care services.
  • Receives payments from private and public insurance plans.
  • Manages costs through its integrated care model and technology platform.
  • Focuses on improving patient outcomes and reducing healthcare costs to drive profitability.

Industry Context

Apollo Medical Holdings operates within the rapidly evolving healthcare industry, which is experiencing a significant shift towards value-based care models. This trend is driven by the need to improve patient outcomes, reduce costs, and enhance the overall efficiency of healthcare delivery. The market for care coordination and population health management is expanding, fueled by increasing demand from both private and public payers. Competitors in this space include companies like AMAM (Ambac Financial Group, Inc.), AMED (Amedisys Inc.), BKDT (Brookdale Senior Living Inc.), BLU (BELLUS Health Inc.), and EMBC (Embecta Corp.), each with varying approaches to healthcare delivery. Apollo Medical Holdings differentiates itself through its physician-centric approach and technology-powered platform.

Key Customers

  • Patients covered by private insurance plans.
  • Patients covered by public insurance plans (Medicare, Medicaid).
  • Non-insured patients in California.
  • Primary care physicians, specialists, and hospitalists within its network.
AI Confidence: 71% Updated: Feb 8, 2026

Financials

Chart & Info

Apollo Medical Holdings, Inc. (AMEH) stock price: $40.82 (-0.88, -2.11%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMEH.

Price Targets

Wall Street price target analysis for AMEH.

MoonshotScore

55/100

What does this score mean?

The MoonshotScore rates AMEH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About Apollo Medical Holdings, Inc. (AMEH) — Healthcare

What does Apollo Medical Holdings, Inc. do?

Apollo Medical Holdings, Inc. operates as a physician-centric, technology-powered healthcare company. It provides medical care services, leveraging its proprietary population health management and healthcare delivery platform. The company's integrated, value-based healthcare model empowers physicians to deliver enhanced care to patients. AMEH offers care coordination services, connecting patients, families, primary care physicians, specialists, acute care hospitals, alternative inpatient care sites, physician groups, and health plans. It primarily serves patients covered by private or public insurance in California, focusing on improving patient outcomes and managing population health.

Is AMEH stock worth researching?

AMEH stock presents a mixed investment profile. While the company's integrated, value-based care model and technology-driven platform offer significant growth potential, its high P/E ratio of 108.83 suggests that the stock may be overvalued. Investors may want to evaluate the company's growth prospects, particularly in the expanding value-based care market, against its current valuation. The company's focus on care coordination and population health management positions it to benefit from the increasing demand for efficient and effective healthcare delivery, making it a potentially attractive investment for those seeking exposure to the healthcare sector.

What are the main risks for AMEH?

Apollo Medical Holdings faces several key risks. Changes in healthcare regulations and reimbursement policies could significantly impact its revenue and profitability. Increased competition from other healthcare providers could erode its market share. An economic downturn could affect patient access to care, reducing demand for its services. Cybersecurity risks and data breaches pose a threat to patient privacy and data security. The company's dependence on government and private insurance reimbursement makes it vulnerable to changes in payer policies. These risks should be carefully considered before investing in AMEH.

What are the key factors to evaluate for AMEH?

Apollo Medical Holdings, Inc. (AMEH) currently holds an AI score of 55/100, indicating moderate score. The stock trades at a P/E of 53.1x, above the S&P 500 average (~20-25x), suggesting high growth expectations. Key strength: Integrated, value-based care model. Primary risk to monitor: Changes in healthcare regulations and reimbursement policies. This is not financial advice.

How frequently does AMEH data refresh on this page?

AMEH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AMEH's recent stock price performance?

Recent price movement in Apollo Medical Holdings, Inc. (AMEH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Integrated, value-based care model. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AMEH overvalued or undervalued right now?

Determining whether Apollo Medical Holdings, Inc. (AMEH) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 53.1. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AMEH?

Before investing in Apollo Medical Holdings, Inc. (AMEH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • Future performance is subject to market conditions and company-specific factors.
  • This analysis is for informational purposes only and does not constitute investment advice.
Data Sources

Popular Stocks